Clinical trial
Escalated Single Platelet Inhibition for One Month Plus Direct Oral Anticoagulation in Patients With Atrial Fibrillation and acUte coRonary Syndrome Undergoing percutaneoUS Coronary Intervention
NCT04981041 is registered in ClinicalTrials.gov with Ludwig-Maximilians - University of Munich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Escalated Single Platelet Inhibition for One Month Plus Direct Oral Anticoagulation in Patients With Atrial Fibrillation and acUte coRonary Syndrome Undergoing percutaneoUS Coronary Intervention
- Lead sponsor
- Ludwig-Maximilians - University of Munich
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 16, 2021
- Completion date
- May 30, 2026
- Enrollment
- 602 (actual)
- Sites
- 37
Conditions
As the registry lists them; a condition with its own page is linked.